| |
HCV & HBV National Strategy Report from the Institute of Medicine -
Monday Jan 11 Release & Conference Call
|
| |
| |
http://www.nationalacademies.org
Chronic hepatitis B and hepatitis C cause thousands of cases of liver cancer, liver disease, and death each year Ñ taking the heaviest toll among Asians, Pacific Islanders, and blacks in the U.S. Ñ and these infections account for nearly half of the liver transplantations that must be performed annually. Although they are preventable infections, viral hepatitis rates have not dropped in the United States, pointing to gaps in screening, prevention, and treatment. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C, a new report from the Institute of Medicine, recommends ways to boost awareness among health care and social service providers as well as the general public and steps to improve screening, vaccination, treatment, and control of viral hepatitis.
The IOM will hold a one-hour telephone briefing to release the report beginning at 11 a.m. EST Monday, Jan. 11.
Participating from the committee that wrote the report:
- R. Palmer Beasley (chair), Ashbel Smith Professor and dean emeritus, School of Public Health, University of Texas Health Science Center, Houston
- Dan Church, epidemiologist and adult viral hepatitis coordinator, Massachusetts Department of Health, Jamaica Plain
- Sam So, Lui Hac Minh Professor and director, Asian Liver Center, Stanford University School of Medicine, Stanford, Calif.
Advance copies will be available to reporters only at 10 a.m. EST Friday, Jan. 8. To obtain an embargoed copy of the report or receive the conference call information, reporters should contact the Office of News and Public Information at tel. 202-334-2138 or e-mailnews@nas.edu. The report is embargoed and not for public release before 11 a.m. EST Monday, Jan. 11.
|
|
| |
| |
|
|
|
